NCT06621238 The Effect of Musıc on Labor Paın, Anxıety and Breastfeedıng Success
| NCT ID | NCT06621238 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ataturk University |
| Condition | Labor Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2024-12-07 |
| Primary Completion | 2025-02-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 140 participants in total. It began in 2024-12-07 with a primary completion date of 2025-02-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to examine the effects of music played to primiparous women who had a cesarean section on pain, state anxiety and breastfeeding success.
Eligibility Criteria
Inclusion Criteria: * Caesarean section * Live birth Exclusion Criteria: * Risky pregnancy * Twin pregnancy * Newborn with cleft palate, cleft lip
Contact & Investigator
Sibel ÖZTÜRK, PhD
PRINCIPAL INVESTIGATOR
sibel.ozturk@atauni.edu.tr
Frequently Asked Questions
Who can join the NCT06621238 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Labor Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06621238 currently recruiting?
Yes, NCT06621238 is actively recruiting participants. Contact the research team at sblsbl0606@gmail.com for enrollment information.
Where is the NCT06621238 trial being conducted?
This trial is being conducted at Mardin, Turkey (Türkiye).
Who is sponsoring the NCT06621238 clinical trial?
NCT06621238 is sponsored by Ataturk University. The principal investigator is Sibel ÖZTÜRK, PhD at sibel.ozturk@atauni.edu.tr. The trial plans to enroll 140 participants.